Effect of Topical Mitomycin C on Corneal Endothelium

American Journal of Ophthalmology

Volumn 145, Issue 4, 2008, Pages

  Panda, Anita ^a   Pe'er, Jacob ^a,b   Aggarwal, Anand ^a   Das, Hrishikesh ^a,c   Kumar, Abhiyan ^a   Mohan, Shalini ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c B P KOIRALA INSTITUTE OF HEALTH SCIENCES   (Nepal)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C;

ADULT; AGED; ARTICLE; CELL DENSITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORNEA DISEASE; CORNEA ENDOTHELIUM; CORNEA THICKNESS; DRUG EFFECT; DYSPLASIA; ENDOTHELIUM CELL; EXCISION; FEMALE; FROZEN SECTION; HUMAN; MALE; OCULAR SQUAMOUS NEOPLASIA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS;

EID: 40949144826     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2007.12.004     Document Type: Article

References (37)

1. Lee G.A., and Hirst L.W. Ocular surface squamous neoplasia. Surv Ophthalmol 39 (1995) 429-450
2. Panda A., Sharma N., and Sen S. Frozen section guided excision of squamous cell carcinoma of conjunctiva and cornea. In: Lass J. (Ed). Advances in cornea (1998), Plenum Press, New York, New York 373-377
3. Frucht-Pery J., and Rozenmann Y. Mitomycin C therapy for corneal intraepithelial neoplasia. Am J Ophthalmol 117 (1994) 164-168
4. Tseng S.H., Tsai Y.Y., and Chen F.K. Successful treatment of conjunctival intraepithelial neoplasia with topical mitomycin C. Cornea 16 (1997) 595-597
5. Heigle T.J., Stulting R.D., and Palay D.A. Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C. Am J Ophthalmol 124 (1997) 397-399
6. Frucht-Pery J., Sugar J., Baum J., et al. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia; a multicenter experience. Ophthalmology 104 (1997) 2085-2093
7. Wilson M.W., Hungerford J.L., George S.M., et al. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Am J Ophthalmol 124 (1997) 303-311
8. Akpek E.K., Ertoy D., Kalayci D., et al. Postoperative topical mitomycin C in conjunctival squamous cell neoplasia. Cornea 21 (2002) 12-16
9. Haas K., BenDor D., and Levartovsky S. Treatment of conjunctival corneal intraepithelial neoplasia with topical mitomycin C. Arch Ophthalmol 117 (1999) 544-545
10. Rozenman Y., and Frucht-Pery J. Treatment of conjunctival intraepithelial neoplasia with topical mitomycin C. Cornea 19 (2000) 1-6
11. Kemp E.G., Harnett A.N., and Chatterjee S. Preoperative topical and intraoperative local mitomycin C adjuvant therapy in the management of ocular surface neoplasia. Br J Ophthalmol 86 (2002) 31-34
12. Fucht-Perry J., Rozenman Y., and Pe'er J. Topical mitomycin C for partially excised conjunctival squamous cell carcinoma. Ophthalmology 109 (2002) 548-552
13. Shields C.L., Naseripour M., and Shields J.A. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Am J Ophthalmol 133 (2002) 601-606
14. Prabhasawat P., Tacinvorakup P., Tesavibul N., et al. Topical 0.02% mitomycin C for the treatment of conjunctival and corneal intraepithelial neoplasia and squamous cell carcinoma. Cornea 24 (2005) 443-448
15. Midena E., Angelia C.D., Valenti M., et al. Treatment of conjunctival squamous cell carcinoma with topical 5-Fluorouracil. Br J Ophthalmol 84 (2000) 268-272
16. Yamamoto N., Ohmura T., Suzuki H., et al. Successful treatment with 5-fluorouracil of conjunctival intraepithelial neoplasia refractive to mitomycin C. Ophthalmology 109 (2002) 249-252
17. Maskin S.L. Regression of limbal epithelial dysplasia with topical interferon. Arch Ophthalmol 112 (1994) 1145-1146
18. Vann R.P., and Karp C.L. Perilesional and topical interferon alpha-2b for conjunctival and corneal neoplasia. Ophthalmology 106 (1999) 91-97
19. Karp C.L., Moore J.K., and Rosa Jr. R.H. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Ophthalmology 108 (2001) 1093-1098
20. Schechter B.A., Schrier A., Nagler R.S., et al. Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Cornea 21 (2002) 6-11
21. Pe'er J. Ocular surface squamous neoplasia. Ophthalmol Clin N Am 18 (2005) 1-13
22. Giaconi J.A., and Karp C.L. Current treatment options for conjunctival and corneal intraepithelial neoplasia. Ocul Surf 2 (2003) 66-73
23. Belyea D.A., Dan J.A., Stamper R.L., Lieberman M.F., and Spencer W.H. Late onset of sequential multifocal bleb leaks after glaucoma filtration surgery with 5-fluorouracil and mitomycin C. Am J Ophthalmol 124 (1997) 40-45
24. Rubinfeld R.S., Pfister R.R., Stein R.M., et al. Serious complications of topical mitomycin C after pterygium surgery. Ophthalmology 99 (1992) 1647-1654
25. Hayasaka S., Noda S., Yamamoto Y., and Setogawa T. Postoperative installation of low-dose mitomycin C in the treatment of primary pterygium. Am J Ophthalmol 106 (1988) 715-718
26. Amano S., Motoyama Y., Oshika T., et al. Comparative study of intraoperative mitomycin C and beta irradiation in pterygium surgery. Br J Ophthalmol 84 (2000) 618-621
27. Schraermeyer U., Diestelhorst M., Bieker A., et al. Morphologic proof of the toxicity of mitomycin C on the ciliary body in relation to different application methods. Graefes Arch Clin Exp Ophthalmol 237 (1999) 593-600
28. Mietz H., Addicks K., Diestelhorst M., and Krieglstein G.K. Extraocular application of mitomycin C in a rabbit model: cytotoxic effects on the ciliary body and epithelium. Ophthalmic Surg 25 (1994) 240-244
29. McKelvie P.A., and Daniell M. Impression cytology following mitomycin C therapy for ocular surface squamous neoplasia. Br J Ophthalmol 85 (2001) 1115-1119
30. Salomao D.R., Mathers W.D., Sutphin J.E., Cuevas K., and Folberg R. Cytologic changes in the conjunctiva mimicking malignancy after topical mitomycin C chemotherapy. Ophthalmology 106 (1999) 1756-1760
31. Dudney B.W., and Malecha M.A. Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia. Am J Ophthalmol 137 (2004) 950-951
32. Panda A., Venkateswarlu K., Angra S.K., and Mohan M. Changes in the corneal endothelial cell count as a function of age. Indian J Ophthalmol 33 (1985) 221-223
33. Ventura A.C., Walti R., and Bohnke M. Corneal thickness and endothelial density before and after cataract surgery. Br J Ophthalmol 85 (2001) 18-20
34. Lai L.J., Chen Y.F., Wu S., Tsao Y.P., and Tsai R.J. Long-term evaluation of endothelial cell loss after phacoemulsification. Eur J Ophthalmol 12 (2002) 30-33
35. Lesiewska-Junk H., Kaluzny J., and Malukiewicz-Wisniewska G. Endothelial cell loss induced by phacoemulsification occurs through apoptosis. Chang Gung Med J 24 (2001) 621-627
36. Sihota R., Sharma T., and Agarwal H.C. Intraoperative mitomycin C and the corneal endothelium. Acta Ophthalmol Scand 76 (1998) 80-82
37. Morales A.J., Zadok D., Mora-Retana R., Martinez-Gama E., Robledo N.E., and Chayet A.S. Intraoperative mitomycin and corneal endothelium after photorefractive keratectomy. Am J Ophthalmol 142 (2006) 400-404